pharmacyclics inc (PCYC:NASDAQ GS)
Earnings & Estimates Summary - PHARMACYCLICS INC (PCYC)
2013 revenues at Pharmacyclics Inc. totaled $260.2M USD, while annual earnings equaled $1.52 per share.
Quarterly Earnings & Estimates - PHARMACYCLICS INC (PCYC)
Pharmacyclics Inc.'s Quarterly Earnings
Pharmacyclics Inc. reported 2nd quarter 2014 losses of $0.26 per share on 08/2/2014.
Annual Earnings & Estimates - PHARMACYCLICS INC (PCYC)
Pharmacyclics Inc.'s Annual Earnings
Pharmacyclics Inc. reported annual 2013 earnings of $1.52 per share on 02/22/2014.
Quarterly Revenues - PHARMACYCLICS INC (PCYC)
Pharmacyclics Inc.'s Quarterly Revenues
Pharmacyclics Inc. had 2nd quarter 2014 revenues of $113.0M USD. This bettered the $95.2M USD consensus of the 17 analysts covering the company. This was 106.7% above the prior year's 2nd quarter results.
Annual Revenues - PHARMACYCLICS INC (PCYC)
Pharmacyclics Inc.'s Annual Revenues
Pharmacyclics Inc. had revenues for the full year 2013 of $260.2M USD. This was 217.3% above the prior year's results.
|Actelion Ltd||SFr.115.10 CHF||-4.70|
|Alexion Pharmaceuticals Inc||$181.34 USD||-2.94|
|BioMarin Pharmaceutical Inc||$120.91 USD||-0.74|
|Genmab A/S||kr514.50 DKK||-3.00|
|Vertex Pharmaceuticals Inc||$125.07 USD||-3.87|
|View Industry Companies|